Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F0PK
|
|||
Drug Name |
Indomethacin analog 2
|
|||
Synonyms |
PMID28895472-Compound-21
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIVANDERBILT UNIVERSITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANI
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H14ClNO4
|
|||
Canonical SMILES |
COC1=CC2=C(C=C1)N(C=C2CC(=O)O)C(=O)C3=CC=C(C=C3)Cl
|
|||
InChI |
1S/C18H14ClNO4/c1-24-14-6-7-16-15(9-14)12(8-17(21)22)10-20(16)18(23)11-2-4-13(19)5-3-11/h2-7,9-10H,8H2,1H3,(H,21,22)
|
|||
InChIKey |
DHEMTWWLRLOBKI-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:71026
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dihydrodiol dehydrogenase type I (AKR1C3) | Target Info | Inhibitor; Antagonist; Blocker | [1] |
Target's Patent Info | Dihydrodiol dehydrogenase type I (AKR1C3) | Target's Patent Info | [1] | |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Allopregnanolone biosynthesis | ||||
Androgen biosynthesis | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Arachidonic acid metabolism | ||||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
Reactome | Retinoid metabolism and transport | |||
WikiPathways | Metapathway biotransformation | |||
Benzo(a)pyrene metabolism | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Dec;27(12):1329-1340. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.